HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Daneshgari Selected Research

Drug Therapy (Chemotherapy)

11/2014Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Daneshgari Research Topics

Disease

1Necrosis
11/2014
1Neoplasm Metastasis (Metastasis)
11/2014
1Neoplasms (Cancer)
11/2014
1Prostatic Neoplasms (Prostate Cancer)
11/2014
1Stress Urinary Incontinence
10/2001

Drug/Important Bio-Agent (IBA)

1Small Interfering RNA (siRNA)IBA
11/2014
1Docetaxel (Taxotere)FDA Link
11/2014
1Simvastatin (Zocor)FDA LinkGeneric
11/2014
1necrostatin-1IBA
11/2014
1Metformin (Glucophage)FDA LinkGeneric
11/2014
1Propidium (Propidium Iodide)IBA
11/2014
1Proteins (Proteins, Gene)FDA Link
11/2014
1Annexin A5IBA
11/2014
1Indicators and Reagents (Reagents)IBA
10/2001

Therapy/Procedure

1Castration
11/2014
1Drug Therapy (Chemotherapy)
11/2014